Weekly Recap | BIOCYTOGEN-B -0.72%, consensus target above spotWeekly Review·Nov 14, 2026 at 05:18 AM02315-0.11%
Weekly Recap | BIOCYTOGEN-B +5.86%, consensus target above spotWeekly Review·Nov 7, 2026 at 05:46 AM02315-0.11%
Biocytogen Pharmaceuticals (SEHK:2315) Stock Sinks Despite Profitable Q3 ResultsSimplywall·Oct 30, 2026 at 12:53 PM02315-0.11%688796-3.31%
Biocytogen climbs 6% as CRO leader WuXi AppTec raises guidanceMarket Movers·Oct 28, 2026 at 01:49 AM02315-0.11%
Weekly Recap | BIOCYTOGEN-B -15.58%, a full-week slideWeekly Review·Oct 24, 2026 at 05:19 AM02315-0.11%
Cytogen Extends Equipment Supply Contract Deadline to Dec. 4, 2026PUBT·Oct 20, 2026 at 08:06 AM02315-0.11%